Literature DB >> 24761267

Effects of Alcohol, Coffee, and Tobacco, Alone or in Combination, on Physiological Parameters and Anxiety in a Young Population.

Concepción Vinader-Caerols1, Santiago Monleón1, Carmen Carrasco1, Andres Parra1.   

Abstract

OBJECTIVE: The objective was to evaluate the effects of a single dose of alcohol, caffeine, and nicotine, alone or in combination, on physiological parameters (systolic and diastolic blood pressure [SBP and DBP] and heart rate [HR]) and state-trait anxiety in healthy young volunteers.
METHOD: The procedure reproduces the conditions under which the subjects (n=76) usually ingest alcohol (through an alcoholic beverage), caffeine (through a cup of coffee), and nicotine (by smoking a cigarette), separately or in combination, according to their consumption habits of each individual. SBP and DBP, HR, and state anxiety (SA) were registered before (phase 1) and after (phase 2) treatment.
RESULTS: Intake of alcohol or alcohol-nicotine reduced DBP. Comparisons between control and combined treatment (coffee-alcohol-nicotine) groups revealed a decrease in HR in the former group but not in the latter. The coffee consumers alone exhibited a tendency toward an increase in SA, while the control group showed a tendency toward a decrease in this measure. When Phase 1 and Phase 2 were compared, a decrease was observed in SBP (alcohol and coffee-alcohol groups), DBP (alcohol and alcohol-nicotine groups), HR (all groups, except coffee-alcohol and coffee-alcohol-nicotine groups), and SA (coffee-alcohol-nicotine group).
CONCLUSIONS: (i) A low dose of alcohol, either alone or in combination with a cigarette, decreases DBP but not SBP; (ii) the polyconsumption of coffee, alcohol, and nicotine blocks the adaptation response (the reduction in HR in control subjects in the second phase); (iii) an increase of SA is observed after consuming coffee, while the opposite occurs in control subjects (a decrease of SA).

Entities:  

Year:  2012        PMID: 24761267      PMCID: PMC3621324          DOI: 10.1089/jcr.2012.0018

Source DB:  PubMed          Journal:  J Caffeine Res        ISSN: 2156-5368


  38 in total

1.  Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials.

Authors:  X Xin; J He; M G Frontini; L G Ogden; O I Motsamai; P K Whelton
Journal:  Hypertension       Date:  2001-11       Impact factor: 10.190

Review 2.  Coffee and health: a review of recent human research.

Authors:  Jane V Higdon; Balz Frei
Journal:  Crit Rev Food Sci Nutr       Date:  2006       Impact factor: 11.176

3.  Antagonistic effects of caffeine and alcohol on mental performance parameters.

Authors:  M Hasenfratz; A Bunge; G Dal Prá; K Bättig
Journal:  Pharmacol Biochem Behav       Date:  1993-10       Impact factor: 3.533

4.  Caffeine antagonism of alcohol-induced driving impairment.

Authors:  A Liguori; J H Robinson
Journal:  Drug Alcohol Depend       Date:  2001-07-01       Impact factor: 4.492

Review 5.  Anxiety, anxiety disorders, tobacco use, and nicotine: a critical review of interrelationships.

Authors:  Sandra Baker Morissette; Matthew T Tull; Suzy Bird Gulliver; Barbara Wolfsdorf Kamholz; Rose T Zimering
Journal:  Psychol Bull       Date:  2007-03       Impact factor: 17.737

Review 6.  Caffeine and nicotine: a review of their joint use and possible interactive effects in tobacco withdrawal.

Authors:  J A Swanson; J W Lee; J W Hopp
Journal:  Addict Behav       Date:  1994 May-Jun       Impact factor: 3.913

7.  Coffee consumption and circulating B-vitamins in healthy middle-aged men and women.

Authors:  Arve Ulvik; Stein Emil Vollset; Geir Hoff; Per Magne Ueland
Journal:  Clin Chem       Date:  2008-07-07       Impact factor: 8.327

Review 8.  Is nicotine a key player or spectator in the induction and progression of cardiovascular disorders?

Authors:  Pitchai Balakumar; Jagdeep Kaur
Journal:  Pharmacol Res       Date:  2009-06-24       Impact factor: 7.658

9.  Subjective and cardiovascular responses to nicotine combined with caffeine during rest and casual activity.

Authors:  K A Perkins; J E Sexton; R L Stiller; C Fonte; A DiMarco; J Goettler; A Scierka
Journal:  Psychopharmacology (Berl)       Date:  1994-01       Impact factor: 4.530

10.  Anxiety is not manifested by elevated heart rate and blood pressure in acutely ill cardiac patients.

Authors:  Marla J De Jong; Debra K Moser; Kyungeh An; Misook L Chung
Journal:  Eur J Cardiovasc Nurs       Date:  2004-09       Impact factor: 3.908

View more
  5 in total

1.  A Protocol to Evaluate Retinal Vascular Response Using Optical Coherence Tomography Angiography.

Authors:  David Cordeiro Sousa; Inês Leal; Susana Moreira; Sónia do Vale; Ana S Silva-Herdade; Patrício Aguiar; Patrícia Dionísio; Luís Abegão Pinto; Miguel A R B Castanho; Carlos Marques-Neves
Journal:  Front Neurosci       Date:  2019-06-12       Impact factor: 4.677

2.  Retinal Vascular Reactivity in Type 1 Diabetes Patients Without Retinopathy Using Optical Coherence Tomography Angiography.

Authors:  David Cordeiro Sousa; Inês Leal; Susana Moreira; Sónia do Vale; Ana S Silva-Herdade; Patrício Aguiar; Patrícia Dionísio; Luís Abegão Pinto; Miguel A R B Castanho; Carlos Marques-Neves
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-06-03       Impact factor: 4.799

3.  Study on the effects of combined tea drinking and mental activity after dinner on smokers in China.

Authors:  Zhongbo Chen; Xuechan Yu; Hanlu Gao; Jie Cen; Qianqian Xu; Jing Gong; Sha Li; Mianzhi Ye; Dan Lv; Hui Chen; Hongying Ma; Younuo Wang; Qingwen Su; Yiming Yu; Zaichun Deng
Journal:  Tob Induc Dis       Date:  2022-07-29       Impact factor: 5.163

4.  Young people, young adults and binge drinking.

Authors:  V LA Fauci; R Squeri; P Spataro; C Genovese; N Laudani; V Alessi
Journal:  J Prev Med Hyg       Date:  2019-12-20

5.  A Systematic Review of Efficacy, Safety, and Tolerability of Duloxetine.

Authors:  Daniela Rodrigues-Amorim; José Manuel Olivares; Carlos Spuch; Tania Rivera-Baltanás
Journal:  Front Psychiatry       Date:  2020-10-23       Impact factor: 4.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.